The Food and Drug Administration (FDA) Thursday authorized booster shots of Pfizer and BioNTech’s coronavirus vaccine for 16- and 17-year-olds, a move meant to bolster protection against the delta and emerging omicron variants.The announcement comes…
Source: The Hill